Hermetica Superfood Encyclopedia
The Short Answer
Nobiletin is a polymethoxylated flavonoid concentrated in citrus peels, particularly sweet oranges and tangerines, that exerts anti-inflammatory and metabolic effects primarily by inhibiting NF-κB signaling and modulating AMPK activation. Research in animal models suggests it may support cardiovascular health, glucose metabolism, and neuroprotection, though robust human clinical trials remain limited.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordnobiletin benefits
Synergy Pairings3
Nobiletin — botanical close-up
Health Benefits
Origin & History
Natural habitat
Nobiletin is a polymethoxylated flavonoid naturally found in citrus fruits, particularly concentrated in the peel and white pith of sweet oranges (Citrus sinensis), mandarins, and tangerines. It is extracted through solvent extraction methods, with standardized extracts typically containing 95% or greater pure nobiletin.
“Nobiletin has minimal traditional use as it was only isolated and characterized in the late 20th century. While citrus peel (Chen Pi) has been used in Traditional Chinese Medicine for digestive complaints, nobiletin itself is a modern phytochemical discovery with use based entirely on contemporary research rather than historical practice.”Traditional Medicine
Scientific Research
Important: No human clinical trials have been published for nobiletin. All available evidence comes from preclinical studies including diabetic rat models (PMID: 27279123), platelet function studies in mice (PMID: PMC4543618), and neuroinflammation cell culture models (PMID: 41261295).
Preparation & Dosage
Traditional preparation
No established human dosing exists as no clinical trials have been conducted. Animal studies used 10-25 mg/kg orally in rats and 50 μM in mice. Commercial citrus extracts typically provide 50-500 mg per serving standardized to 10-30% nobiletin content. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Nobiletin is a polymethoxylated flavone (PMF) isolated primarily from citrus peel, particularly sweet orange (Citrus sinensis) and tangerine (Citrus reticulata). It is not a macronutrient or micronutrient source but rather a bioactive polyphenolic compound with molecular formula C21H22O8 and molecular weight 402.39 g/mol. Typical concentrations in citrus peel range from 0.1–1.5 mg/g dry weight, with tangeretin and sinensetin often co-occurring as related PMFs. As a pure compound, it contains no meaningful protein, fiber, or mineral content. Bioavailability is limited by poor aqueous solubility (log P ~3.6), though its methoxy groups confer significantly better intestinal absorption compared to non-methylated flavones like luteolin. Gut microbiota partially demethylate nobiletin into active metabolites (e.g., 3',4'-dihydroxynobiletin), which may contribute to downstream bioactivity. Peak plasma concentrations in rodent studies are typically achieved 1–2 hours post-oral administration, with lipid-based delivery systems shown to enhance bioavailability by approximately 2–3 fold.
How It Works
Mechanism of Action
Nobiletin suppresses inflammatory gene expression by inhibiting the NF-κB signaling cascade, reducing downstream production of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β. It activates AMP-activated protein kinase (AMPK), which improves insulin sensitivity and lipid metabolism by upregulating fatty acid oxidation and inhibiting lipogenic enzyme expression. Additionally, nobiletin inhibits phosphodiesterase (PDE) enzymes, elevating intracellular cAMP and cGMP levels, which contributes to its vasodilatory and platelet aggregation-inhibiting effects.
Clinical Evidence
The majority of nobiletin research consists of in vitro cell studies and rodent models, with very few controlled human trials published to date. In diabetic rat models, nobiletin administration reduced oxidative stress markers and improved endothelial vascular function (PMID: 27279123), while mouse studies demonstrated significant inhibition of collagen- and ADP-induced platelet aggregation. A small number of human observational studies link high dietary polymethoxylated flavonoid intake to improved lipid profiles, but these do not isolate nobiletin specifically. Overall, the evidence base is preliminary and promising but insufficient to establish definitive clinical recommendations for humans.
Safety & Interactions
Nobiletin is generally considered well-tolerated in animal studies at dietary-relevant doses, with no significant toxicity reported at moderate supplemental levels, but comprehensive human safety data are lacking. Because nobiletin inhibits certain cytochrome P450 enzymes, including CYP3A4 and CYP1A2, it may theoretically alter the metabolism of drugs such as statins, calcium channel blockers, and anticoagulants like warfarin, potentially increasing their plasma concentrations. Its platelet aggregation-inhibiting properties suggest caution when combined with antiplatelet drugs such as aspirin or clopidogrel, or anticoagulants, due to additive bleeding risk. Pregnant or breastfeeding individuals should avoid supplemental nobiletin due to the absence of safety data in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
5,6,7,8,3',4'-HexamethoxyflavonePMF (Polymethoxylated Flavonoid)Citrus NobiletinHexamethoxyflavoneChen Pi extract component
Frequently Asked Questions
What foods are highest in nobiletin?
Nobiletin is found almost exclusively in citrus fruit peels, with sweet oranges (Citrus sinensis) and tangerines (Citrus reticulata) being the richest sources, containing approximately 0.5–5 mg of nobiletin per gram of dried peel. Cold-pressed citrus peel oils and certain citrus juices contain smaller amounts, but consuming the whole fruit flesh provides negligible nobiletin compared to the peel.
What is the studied dosage of nobiletin in research?
Animal studies have used doses ranging from 10 to 100 mg/kg body weight per day, which does not translate directly to human equivalents without allometric scaling. Using the FDA body surface area conversion, a 100 mg/kg mouse dose approximates roughly 8–10 mg/kg in humans, suggesting effective human doses could fall in the range of 500–800 mg/day for a 70 kg adult, though no established human clinical dosage currently exists.
Can nobiletin help with weight loss or metabolic syndrome?
In high-fat diet mouse models, nobiletin supplementation at 50–100 mg/kg significantly reduced adipose tissue accumulation, lowered fasting blood glucose, and improved insulin sensitivity through AMPK activation and suppression of SREBP-1c-mediated lipogenesis. While these metabolic effects are consistently replicated across multiple rodent studies, no randomized controlled human trials have yet confirmed equivalent outcomes for weight loss or metabolic syndrome in people.
Does nobiletin cross the blood-brain barrier?
Yes, nobiletin has demonstrated the ability to cross the blood-brain barrier in rodent studies, which is attributed to its highly lipophilic polymethoxylated structure that facilitates passive membrane diffusion. In Alzheimer's disease mouse models, brain-penetrant nobiletin reduced amyloid-beta plaque burden and improved cognitive performance on maze tasks, supporting its potential as a neuroprotective agent, though human brain bioavailability data are not yet established.
Is nobiletin the same as hesperidin or quercetin?
No, nobiletin is structurally distinct from both hesperidin and quercetin. Nobiletin is a polymethoxylated flavone with six methoxy groups attached to its flavone backbone, whereas hesperidin is a flavanone glycoside and quercetin is a hydroxylated flavonol. This unique polymethoxylation pattern makes nobiletin significantly more lipophilic and potentially more bioavailable across cell membranes compared to heavily hydroxylated flavonoids like quercetin, and is responsible for its distinct pharmacological profile.
Does nobiletin interact with blood thinners or antiplatelet medications?
Nobiletin may have mild antiplatelet effects based on in vitro and animal studies showing platelet aggregation inhibition, which could theoretically potentiate blood thinners like warfarin or aspirin. However, human clinical data on drug interactions is extremely limited, and the physiological relevance of in vitro findings at typical supplement doses remains unclear. Anyone taking anticoagulant or antiplatelet medications should consult their healthcare provider before adding nobiletin supplements. More human safety studies are needed to establish safe co-administration guidelines.
What is the bioavailability of nobiletin, and does it vary by food source versus supplement form?
Nobiletin bioavailability is generally low when ingested orally, with limited human pharmacokinetic data available to compare citrus food sources against isolated supplement forms. Animal studies suggest that nobiletin may undergo first-pass metabolism and has poor intestinal absorption, though co-consumption with dietary fats or other citrus compounds may enhance uptake. Research directly comparing the bioavailability of nobiletin from whole citrus fruits versus standardized extracts in humans is lacking. Until more comparative studies emerge, the optimal source and absorption-enhancing strategies for nobiletin supplementation remain uncertain.
What is the current strength of clinical evidence supporting nobiletin for cardiovascular and brain health?
The evidence base for nobiletin remains mostly preclinical, relying heavily on cell culture and animal model studies (particularly diabetic rats and mice) rather than robust human clinical trials. While these studies show promising anti-inflammatory and antioxidant mechanisms, translating these findings to human benefit requires large-scale, well-controlled clinical trials that are currently lacking. Only a handful of observational or small human studies exist, making it premature to make definitive health claims about cardiovascular or neurological benefits in people. Consumers should view nobiletin as a research-stage ingredient with theoretical promise rather than an established therapeutic agent.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w nobiletin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
